In vitro assessment of the effect of vaccine-targeted human papillomavirus (HPV) depletion on detection of non-vaccine HPV types: Implications for post-vaccine surveillance studies

Alyssa M. Cornall, Samuel Phillips, Eleanor Cummins, Suzanne M. Garland, Sepehr N. Tabrizi

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)


In populations where the prevalence of vaccine-targeted HPV types has been reduced significantly due to widespread vaccination of the target population, the sensitivity of some consensus PCR-based assays to detect remaining HPV types may be altered, leading to misrepresentations of prevalence. Importantly, this may lead to false indications of type replacement in vaccinated populations. To assess whether excess vaccine-targeted HPV DNA resulted in reduced detection of other genotypes on the Roche HPV linear array genotype assay, simulated samples containing 1000 copies of one or two high-risk HPV DNA genomes in the presence and the absence of 10,000 copies of the HPV16 genome were tested. HPV16 alone did not affect detection of other high-risk genotypes; however when HPV16 and an additional genotype were present, detection of HPV31, 33, 51 or 59 was impeded, indicating potential for misrepresentation of population-based prevalence of these genotypes and false evidence for type replacement following vaccination.

Original languageEnglish
Pages (from-to)10-14
Number of pages5
JournalJournal of Virological Methods
Publication statusPublished - 15 Mar 2015
Externally publishedYes


  • False negatives
  • Genotyping
  • HPV
  • Surveillance
  • Type replacement
  • Vaccine

Cite this